Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
14.60
-0.51 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
14.88
+0.28 (1.92%)
After-hours: Apr 28, 2026, 4:56 PM EDT
Tenax Therapeutics Employees
As of December 31, 2025, Tenax Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change (1Y)
10
Growth (1Y)
166.67%
Revenue / Employee
n/a
Profits / Employee
-$3,287,438
Market Cap
859.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Alpha Tau Medical | 121 |
| Solid Biosciences | 121 |
| BridgeBio Oncology Therapeutics | 92 |
| Lexicon Pharmaceuticals | 81 |
| Vor Biopharma | 76 |
| Design Therapeutics | 54 |
TENX News
- 6 days ago - Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Tenax Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Tenax Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 2 months ago - Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 - GlobeNewsWire
- 4 months ago - Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - GlobeNewsWire
- 5 months ago - Tenax Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts